Literature DB >> 3422035

A multivariate analysis of pathologic prognostic indicators in large bowel cancer.

T Wiggers1, J W Arends, B Schutte, L Volovics, F T Bosman.   

Abstract

A multivariate analysis of the pathologic data of 350 patients with primary colorectal cancer was performed. In addition to conventional parameters such as shape and size of the primary tumor, central node involvement, angioinvasive growth, grade, and stage, new variables such as the immunoreactivity patterns of carcinoembryonic antigen (CEA), CA 19-9, mucin, serotonin, secretory component (SC), and the DNA index were tested for their potential prognostic value. Every variable except CA 19-9, serotonin, and DNA showed significant prognostic information in univariate analysis. However, in the multivariate analysis stage was the predictive factor with the highest hazard ratio, but absence of central node involvement, tumors with diameters between 3.5 cm and 6 cm, exophytic tumor growth, well-differentiated tumors, tumors with CEA immunoreactivity, absence for staining with serotonin, and diploid tumors also were included in the relative risk model. Thus, the aforementioned variables appear to play a role in the establishment of a prognostic index.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422035     DOI: 10.1002/1097-0142(19880115)61:2<386::aid-cncr2820610231>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  42 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome.

Authors:  Valeria Barresi; Carmela Di Gregorio; Luca Regiani-Bonetti; Maurizio Ponz-De Leon; Gaetano Barresi; Enrica Vitarelli
Journal:  Virchows Arch       Date:  2010-06-08       Impact factor: 4.064

3.  Nodal spread and micrometastasis within mesorectum.

Authors:  Cun Wang; Zong-Guang Zhou; Zhao Wang; Dai-Yun Chen; Yang-Chun Zheng; Gao-Ping Zhao
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 4.  Genetics of colon cancer.

Authors:  D J Ahnen
Journal:  West J Med       Date:  1991-06

5.  Flow cytometry in colon cancer: does flow cytometric cell cycle analysis help predict for short-term recurrence in patients with colorectal carcinoma?

Authors:  C Hixon; J Furlong; A Silbergleit
Journal:  J Natl Med Assoc       Date:  1995-11       Impact factor: 1.798

6.  The relationship between tumour volume and the extent of spread in colorectal carcinoma.

Authors:  K W Scott; R H Grace
Journal:  Int J Colorectal Dis       Date:  1994       Impact factor: 2.571

7.  Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Giovanni Branca; Carmela Di Gregorio; Maurizio Ponz de Leon; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2012-10-24       Impact factor: 4.064

8.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 9.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

10.  Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Authors:  M Goggins; G J Offerhaus; W Hilgers; C A Griffin; M Shekher; D Tang; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.